e-learning
resources
Courses
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Managing end stage disease in ILDs
M. Vasakova (Praha, Czech Republic)
Source:
ERS Course 2019 - Interstitial Lung Diseases
Number:
26
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Vasakova (Praha, Czech Republic). Managing end stage disease in ILDs. ERS Course 2019 - Interstitial Lung Diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Treatment of advanced CF lung disease and end of life care
Source: ERS course 2015
Year: 2015
Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Evaluating the effects of pulmonary rehabilitation in patients with COPD in early and late disease stages.
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008
Association of caregiver burden and depression in caregivers of patients with chronic respiratory failure secondary to advanced and end stage lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?
Source: Eur Respir J 2011; 37: 489-491
Year: 2011
Symptoms management of advanced lung disease
Source: Annual Congress 2004 - Palliative care in lung disease
Year: 2004
Treatment of advanced cystic fibrosis lung disease and end of life decisions
Source: School Course 2013 - Cystic Fibrosis
Year: 2013
COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Empyema: How to prevent progression to stage III disease
Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques
Year: 2019
Empyema: How to prevent progression to stage III disease
Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019
Year: 2019
Empyema: How to prevent progression to stage III disease
Source: ERS Skills Course 2018 - Thoracoscopy and pleural techniques
Year: 2018
Monitoring disease progression in COPD patients: one step beyond!
Source: Eur Respir J 2014; 43: 665-667
Year: 2014
How to prevent progression to stage III disease
Source: International Congress 2016 – An update on pleural empyema diagnostics and treatment
Year: 2016
Delay in diagnosis of COPD leading to poor prognosis of disease
Source: International Congress 2015 – Different data in COPD
Year: 2015
Challenging infections in advanced CF lung disease
Source: Annual Congress 2013 –Challenges in lung transplantation for cystic fibrosis
Year: 2013
Markers of early disease and prognosis in COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Features affecting stages of patients with lung cancer at diagnosis
Source: Eur Respir J 2005; 26: Suppl. 49, 536s
Year: 2005
Do nocturnal apnoeas contribute to increased cardiovascular risk in end stage renal disease patients?
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008
Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept